Home LiteratureArticle Details
PMID: 19468851 Published · ppublish English Journal Article

BioCores: identification of a drug/natural product-based privileged structural motif for small-molecule lead discovery.

Molecular diversity ·Vol. 14 ·No. 1 ·2010-02-00 ·Pages 193-200

Kombarov R, Altieri A, Genis D, Kirpichenok M, Kochubey V, Rakitina N, Titarenko Z

Abstract

The analysis of known drugs (Comprehensive Medicinal Chemistry database (2008 version): http://www.mdl.com/products/knowledge/medicinal_chem/index.jsp ) and natural products (Koch et al., Proc Natl Acad Sci USA 102:17272-17277, 2008) has led to the identification of privileged saturated and aromatic heterocyclic ring pairs that we have termed as "BioCores." This article explains how the BioCores can be used for the design of novel lead-like scaffolds.

MeSH Terms
Alkaloids/chemistry Biological Products/chemistry Databases, Factual Drug Discovery/methods Heterocyclic Compounds/chemistry Pharmaceutical Preparations/chemistry Small Molecule Libraries
Chemicals
Alkaloids Biological Products Heterocyclic Compounds Pharmaceutical Preparations Small Molecule Libraries
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Kombarov Roman
ASINEX Ltd, 20 Geroev Panfilovtzev Str. Bldg 1, Moscow, 125480, Russia. rkombarov@asinex.com
Altieri Andrea
Genis Dmitry
Kirpichenok Mikhail
Kochubey Valeriy
Rakitina Natalia
Titarenko Zoya
References (10)
10 references, click to expand
  1. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):218-27 PMID: 12546556
  2. The role of natural product chemistry in drug discovery.
    J Nat Prod. 2004 Dec;67(12):2141-53 PMID: 15620274
  3. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
    Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 PMID: 11259830
  4. Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection.
    Curr Top Med Chem. 2005;5(4):397-411 PMID: 15892682
  5. Novel chemical space exploration via natural products.
    J Med Chem. 2009 Apr 9;52(7):1953-62 PMID: 19265440
  6. Molecular diversity in the context of leadlikeness: compound properties that enable effective biochemical screening.
    Curr Opin Chem Biol. 2008 Jun;12(3):340-51 PMID: 18328272
  7. Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology.
    J Med Chem. 2008 Mar 13;51(5):1214-22 PMID: 18288794
  8. Charting biologically relevant chemical space: a structural classification of natural products (SCONP).
    Proc Natl Acad Sci U S A. 2005 Nov 29;102(48):17272-7 PMID: 16301544
  9. How many drug targets are there?
    Nat Rev Drug Discov. 2006 Dec;5(12):993-6 PMID: 17139284
  10. The properties of known drugs. 1. Molecular frameworks.
    J Med Chem. 1996 Jul 19;39(15):2887-93 PMID: 8709122
Article Info
Journal
Molecular diversity
Abbr.
Mol Divers
ISSN
1573-501X
Published
2010-02-00
Epub
2009-00-26
Pages
193-200
Language
English
Region
Netherlands
NLM ID
9516534
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com